Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Alimera Sciences, Inc.
Pharmaceutical Preparations GA, United States
Nasdaq: ALIM
Company Description
Alimera Sciences, Inc. is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. It focuses on diseases affecting the back of the eye, or retina. Its primary product, ILUVIEN, is an intravitreal implant containing fluocinolone acetonide, a non-proprietary corticosteroid with demonstrated efficacy in the treatment of ocular disease. The ILUVIEN product is an antidote for the treatment of diabetic macular edema, a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness. Alimera Sciences was founded on June 4, 2003 by C. Daniel Myers and David R. Holland and is headquartered in Alpharetta, GA.
Similar to: Sanofi, AstraZeneca Plc, Columbia Laboratories, Inc.
Featured Company
Aben Resources Ltd.
Vancouver, BC, CA
Aben Resources (TSX.V: ABN) is a Canadian gold and silver exploration company with a focus on developing properties in the Yukon.… Learn more →
Social Monitor
You may also be interested in:
Columbia Laboratories, Inc.
Livingston, NJ, US
Columbia Laboratories, Inc. develops, manufactures and sells pharmaceutical products. Its pharmaceutical products include CRINONE… Learn more →
AstraZeneca Plc
London, LO, GB
AstraZeneca Plc is a global research-based biopharmaceutical company, which discovers, develops and markets medicines for gastrointestinal,… Learn more →
Sanofi
Paris, FR
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’… Learn more →